Chrysin and its emerging role in cancer drug resistance

Chemico-Biological Interactions

Volumn 236, Issue , 2015, Pages 7-8

  Kasala, Eshvendar Reddy ^a   Bodduluru, Lakshmi Narendra ^a   Barua, Chandana C ^b   Gogoi, Ranadeep ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b ASSAM AGRICULTURAL UNIVERSITY   (India)

Author keywords

Apoptosis; Cancer therapy; Chrysin; Cisplatin; Drug resistance

Indexed keywords

2 METHOXYESTRADIOL; BREAST CANCER RESISTANCE PROTEIN; CHRYSIN; CISPLATIN; CURCUMIN; PROTEIN P53; ROTENONE; FLAVONOID;

APOPTOSIS; CANCER RESISTANCE; CHEMOSENSITIZATION; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SAFETY; HEPG2 CELL LINE; LETTER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL DESTRUCTION; DRUG EFFECTS; GENETICS; HUMAN;

APOPTOSIS; CISPLATIN; FLAVONOIDS; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929463624     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.04.017     Document Type: Article

References (7)

1. D.A. Yardley Drug resistance and the role of combination chemotherapy in improving patient outcomes Int. J. Breast Cancer 2013 2013 137414 10.1155/2013/137414
2. X. Li, J.M. Huang, J.N. Wang, X.K. Xiong, X.F. Yang, and F. Zou Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up regulating p53 Chem. Biol. Interact. 232 2015 12 20 10.1016/j.cbi.2015.03.003
3. E.R. Kasala, L.N. Bodduluru, R.M. Madana, K.V. Athira, R. Gogoi, and C.C. Barua Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives Toxicol. Lett. 233 2 2015 214 225 10.1016/j.toxlet.2015.01.008
4. H.W. Wang, C.P. Lin, J.H. Chiu, K.C. Chow, K.T. Kuo, and C.S. Lin et al. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in non-small cell lung cancer cells by wogonin and chrysin Int. J. Cancer 120 2007 2019 2027
5. A.M. Gao, Z.P. Ke, F. Shi, G.C. Sun, and H. Chen Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/ Nrf2 pathway Chem. Biol. Interact. 206 1 2013 100 108 10.1016/j.cbi.2013.08.008
6. S. Zhang, X. Yang, and M.E. Morris Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport Mol. Pharmacol. 65 5 2004 1208 1216
7. R. Kachadourian, H.M. Leitner, and B.J. Day Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion Int. J. Oncol. 31 1 2007 161 168